These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23580066)

  • 1. Update in endocrinology: evidence published in 2012.
    Schlechte JA
    Ann Intern Med; 2013 Jun; 158(11):821-4. PubMed ID: 23580066
    [No Abstract]   [Full Text] [Related]  

  • 2. n-3 fatty acids and cardiovascular outcomes in dysglycemia.
    Hurtado-Torres GF; Sandoval-Munro RL
    N Engl J Med; 2012 Nov; 367(18):1760-1; author reply 1761. PubMed ID: 23113492
    [No Abstract]   [Full Text] [Related]  

  • 3. n-3 fatty acids and cardiovascular outcomes in dysglycemia.
    Levy Y
    N Engl J Med; 2012 Nov; 367(18):1760; author reply 1761. PubMed ID: 23113491
    [No Abstract]   [Full Text] [Related]  

  • 4. Basal insulin and cardiovascular and other outcomes.
    Leow MK
    N Engl J Med; 2012 Nov; 367(18):1763; author reply 1763-4. PubMed ID: 23113497
    [No Abstract]   [Full Text] [Related]  

  • 5. Basal insulin and cardiovascular and other outcomes.
    Ceriello A
    N Engl J Med; 2012 Nov; 367(18):1762-3; author reply 1763-4. PubMed ID: 23113496
    [No Abstract]   [Full Text] [Related]  

  • 6. Basal insulin and cardiovascular and other outcomes.
    Schernthaner G; Currie CJ
    N Engl J Med; 2012 Nov; 367(18):1762; author reply 1763-4. PubMed ID: 23113495
    [No Abstract]   [Full Text] [Related]  

  • 7. Basal insulin and cardiovascular and other outcomes.
    Vigneri R; Vigneri P; Frittitta L
    N Engl J Med; 2012 Nov; 367(18):1761-2; author reply 1763-4. PubMed ID: 23113494
    [No Abstract]   [Full Text] [Related]  

  • 8. Bariatric surgery or medical therapy for obesity.
    Frontoni S; Malandrucco I; Bonadonna RC
    N Engl J Med; 2012 Aug; 367(5):473-4; author reply 474-6. PubMed ID: 22853020
    [No Abstract]   [Full Text] [Related]  

  • 9. Bariatric surgery or medical therapy for obesity.
    Gletsu-Miller N; Ziegler TR
    N Engl J Med; 2012 Aug; 367(5):473; author reply 474-6. PubMed ID: 22853019
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgery or medical therapy for obese patients with type 2 diabetes?
    Zimmet P; Alberti KG
    N Engl J Med; 2012 Apr; 366(17):1635-6. PubMed ID: 22449318
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on ORIGIN trial.
    Mazzucchelli C; Bordone C; Maggi D; Cordera R
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):e33-4. PubMed ID: 23786822
    [No Abstract]   [Full Text] [Related]  

  • 12. N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia.
    Kromhout D
    Evid Based Med; 2013 Aug; 18(4):e34. PubMed ID: 23173155
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine for thyroid cancer--is less more?
    Alexander EK; Larsen PR
    N Engl J Med; 2012 May; 366(18):1732-3. PubMed ID: 22551133
    [No Abstract]   [Full Text] [Related]  

  • 14. Well-being after radiation therapy in thyroid cancer.
    Hackshaw A; Kadalayil L; Mallick U
    N Engl J Med; 2013 Feb; 368(7):685-6. PubMed ID: 23406048
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine ablation in low-risk thyroid cancer.
    Orlov S; Freeman JL; Walfish PG
    N Engl J Med; 2012 Aug; 367(7):672; author reply 673-5. PubMed ID: 22894582
    [No Abstract]   [Full Text] [Related]  

  • 16. Bariatric surgery or medicine for type 2 diabetes?
    Doggrell SA; Chan V
    Expert Opin Pharmacother; 2012 Oct; 13(15):2249-53. PubMed ID: 22957791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer: successful remnant ablation-what is success?
    Links TP; van der Horst-Schrivers AN
    Nat Rev Endocrinol; 2012 Sep; 8(9):514-5. PubMed ID: 22751340
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

  • 19. Zoledronate, fractures, and mortality after hip fracture.
    van den Berg P
    N Engl J Med; 2008 Feb; 358(9):967; author reply 968-9. PubMed ID: 18305273
    [No Abstract]   [Full Text] [Related]  

  • 20. Fracture risk and zoledronic acid in men with osteoporosis.
    Turgeon RD; Yeung SS
    N Engl J Med; 2013 Feb; 368(9):872-3. PubMed ID: 23445104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.